Similar Papers

Paper Title
Journal
Date
Author
Diversity of Serotype Replacement After Pneumococcal Conjugate Vaccine Implementation in Europe
Corinne Levy ... Robert Cohen
The Journal of Pediatrics | VOL. 213
Corinne Levy, et. al.Corinne Levy ... Robert Cohen
24 Sep 2019
Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity.
Ron Dagan ... Drora Fraser
The Pediatric Infectious Disease Journal | VOL. 19
Ron Dagan, et. al.Ron Dagan ... Drora Fraser
01 May 2000
Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study
Shrijana Shrestha ...
The Lancet Global Health | VOL. 10
Shrijana Shrestha, et. al.Shrijana Shrestha ...
13 Sep 2022
Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia.
Abel Abera Negash ... Meseret Gebre
Open Forum Infectious Diseases | VOL. 6
Abel Abera Negash, et. al.Abel Abera Negash ... Meseret Gebre
31 May 2019
View more papers

More From: Vaccine

Paper Title
Journal
Date
Author
Epidemiology and clinical burden of invasive pneumococcal disease in older adults in the city of São Paulo, Brazil.
Daniel Jarovsky ... Thais Das Neves Fraga Moreira
Vaccine | VOL. 54
Daniel Jarovsky, et. al.Daniel Jarovsky ... Thais Das Neves Fraga Moreira
18 Mar 2025
Implementation of school-based vaccination in French middle schools: Efficient or not?
Aurelie Baldolli ... Jocelyn Michon
Vaccine | VOL. 55
Aurelie Baldolli, et. al.Aurelie Baldolli ... Jocelyn Michon
18 Mar 2025
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45years of age.
Theresa E Hegmann ... Patricia Winokur
Vaccine | VOL. 54
Theresa E Hegmann, et. al.Theresa E Hegmann ... Patricia Winokur
18 Mar 2025
Challenges and lessons learned during the switching of rotavirus vaccine from Rotarix to Rotavac in Zambia.
E.M Mpabalwani ... J.M Mwenda
Vaccine | VOL. 55
E.M Mpabalwani, et. al.E.M Mpabalwani ... J.M Mwenda
18 Mar 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.